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Background: In developing countries, accessibility to specialists, and physician to patient contact time is limited. In
Thailand, A unique community health service is provided by subdistrict health care officers and Village Health
Volunteers (VHVs). If the personnel were trained on proper chronic kidney disease (CKD) care, CKD progression
would be delayed.
Methods/Design: We conducted a community-based, cluster randomized controlled trial at Kamphaeng Phet
Province, located about 400 kilometers north of Bangkok. Two out of eleven districts of the province were randomly
selected. Approximatly 500 stage 3–4 CKD patients from 2 districts were enrolled. Patients in both groups will be
treated with standard guidelines. The patients in intervention group were provided the additional treatments by
multidisciplinary team in conjunction with community CKD care network (subdistrict health care officers and VHVs)
which will provide group counseling during each hospital visit and quarterly home visits to monitor dietary protein
and sodium intake, blood pressure measurement and drug compliance. Duration of the study is 2 years. The
primary outcome is the difference of rate of eGFR decline. The secondary outcomes are laboratory parameters and
incidence of clinical endpoints such as mortality rate and cardiovascular events, end-stage renal disease (ESRD), etc.
Discussion: Insights of this study may set forth a new standard of community-based CKD care.
Trial registration: NCT01978951.
Keywords: Chronic kidney disease, Integrated CKD care program, Village health volunteersBackground
According to a recent community-based survey among
Thais, the prevalence of pre-dialysis (stage 3, 4 and 5)
CKD was 8.8% [1]. It is estimated that the total number
of stage 3–4 CKD patients in Thailand is 4.1 millions.
With only 450 active nephrologists, the ratio of CKD pa-
tients to nephrologists in Thailand is as high as 1:15,000.
The high ratio indicates that accessibility to nephrologist* Correspondence: teerayut065@yahoo.com
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article, unless otherwise stated.may not be equal for all CKD patients. At present, Thai
CKD care is still based on conventional method in which
a hospital-based, physician-oriented approach provided
at the out-patient department [2-4]. In rural areas where
physician-to-patient contact time is more limited and
renal specialists are scarce or not existing, this kind of
health care service is impractical. Thus, it is mandatory
to seek other appropriate forms of renal care to delay
CKD progression.
Thailand is geographically divided into 77 provinces.
Each is divided into 5–10 districts and further into 5–10
subdistricts per district. In general, a typical subdistrictCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Map of Thailand.
Figure 2 Map of Kamphaeng Phet Province. The numbers
represent respective districts of the Province. District No.5 and No.8
denote Khlong Khlung District (Intervention group) and Sai Thong
Wattana District (Control group), respectively.
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households. At the district level, there is one district
hospital consisting of 3–5 general practioners providing
all basic medical services including maternal and child
health care, simple trauma, diabetes and hypertension.
There is one subdistrict health care office in each sub-
district, with 1–2 nurses, 3–5 subdistrict health care of-
ficers, and 100–120 village health volunteers (VHVs).
Healthcare personnel of each subdistrict involved in
various community health activities, for example, anti-
smoking campaign, HIV prevention, etc.
The VHVs are villagers voluntarily recruited from their
own villages. Each VHV is responsible for 10–15 house-
holds. They work as a bridging point between villagers
and health care personnel at the subdistrict health offi-
ces or district hospitals. At the moment, there are about
980,000 VHVs covering more than 90% of all villages in
Thailand. With continued and unrelenting contact be-
tween VHVs and their respective household villagers,
the intimate bonding” and “sense-of-belonging” relation-
ship is created. The VHV scheme serves as the backbone
of community-based public health service in Thailand.
This system is so successful that Thailand is regarded as
one of a few developing countries that have efficient pri-
mary health care service [5,6].
Should the paramedical personnel be trained to render
proper CKD care, it would be interesting whether their
intimate relationship and commitment to their respon-
sible village households will result in better outcome
when compared with the conventional care. The aim of
this study is to compare the effectiveness on delaying
CKD progression between a conventional care and an in-
tegrated CKD care provided by multidisciplinary team of
hospital staffs in conjunction with the community CKD
care network (subdistrict health care officers and VHVs).
Methods
Study design
The ESCORT study is a community-based, cluster ran-
domized controlled trial. Duration of the study is 2
years. This study has been conducted at Kamphaeng
Phet Province, located about 400 kilometers north of
Bangkok (Figure 1 and Figure 2). Due to strong rela-
tionship among neighboring households in rural com-
munities, it is unable to assign subjects living in the same
district to be randomly received either of the 2 CKD care
programs without crossover interference from one subject
in one household to another. As a result, we have con-
ducted a cluster randomized controlled trial. Two out
of eleven districts of the Province, namely Sai Thong
Wattana District (control group) and Khlong Khlung
District (intervention group), were randomly selected.
Details of Public health characteristics of these 2 dis-
tricts were described in Table 1.






Total population 23,821 73,374
Occupation: farmer (%) 80 80
No. of subdistricts 3 10
No. of villages 38 103
No. of personnel at the district hospitals
• General practitioners 3 5
• Nurses 25 54
• Pharmacists 2 5
• Nutritionists 0 1
No. of personnel at each subdistrict health office
• Nurses 1 1
• Subdistrict health care officers 3-5 3-5
No. of village health volunteers per village 10-12 10-12
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The study was approved by the Ethics Committee of
Institutional Review Board of Ministry of Public Health,
Thailand and was registered with www.clinicaltrials.gov
(NCT01978951). Written inform consents were obtained
prior to recruitment. The study was conducted in accord-
ance with good clinical practice and the Declaration of
Helsinki [7]. Eligible cases are those who live in these 2
districts, age of 18–70 years old and had diabetes and/or
hypertension. Patients whose eGFR was in a range of 15–
59 ml/min/1.73 m2 body surface area estimated twice at
3 months apart were asked to participate in this study.
Creatinine-based estimated glomerular filtration rate
(eGFR) was calculated with the CKD-EPI equation [8].
Patients were excluded if they have any of the following:
unstable/advanced cardiovascular disease, obstructive uro-
pathy, ESRD, HIV infection, pregnancy, body mass index
(BMI) less than 18 or more than 40 kg/m2, being under
treatment for malignancy, urine protein-creatinine ratio
more than 3.5 g/g creatinine and active urinary sediment
(urine red blood cells more than 3 cells/high power field
or urine white blood cells more than 10 cells/high power
field). Hypertension was defined as a systolic blood pres-
sure higher than 140 mmHg or a diastolic blood pressure
higher than 90 mmHg or concomitant use of antihyperten-
sive medications [9]. Blood pressure was recorded twice
with a sphygmomanometer with 15-minute rest between
the measurements. Diabetes was diagnosed when a fasting
plasma glucose is at or above 126 mg/dl or HbA1C at or
above 6.5 percent twice after repeated measurements [10].
Sample size
In a previous observational study, the rate of eGFR de-
cline among diabetic patients with overt nephropathy was4.2 ± 3.8 ml/min/1.73 m2 BSA per year [11]. We hypothe-
sized that if the rate of eGFR decline of intervention group
is less than control group at least 1 ml/min/1.73 m2 per
year, the primary outcome of the study will be interpreted
as significant. To acheive 80 percent or higher power to
detect the difference between the two treatments, it was
estimated that 228 stage 3–4 CKD patients were needed
to be enrolled to each group [12]. Taking into account that
15% of patients might be loss to follow-up because of
non–end point death or other reasons, approximately 250
patients for each group were required.
According to the inclusion and exclusion criteria, re-
cruitment had done in January to June 2011. About 25%
of candidates were eligible and asked to participate in
the study. The main reason for non-participation was in-
ability of the patient and caregiver to attend the anti-
cipated visits. In July 2011, 433 patients had been
enrolled . Enrolled subjects of each group will be further
subdivided into 12 patient subgroups with respect to the
vicinity of their subdistrict. Each subgroup will consist of
25–30 CKD patients.
Interventions
Two types of CKD care programs will be provided sep-
arately according to their respective district of residence.
CKD patients residing in district No.8 will be assigned
to the control group and those in district No.5 will be
assigned to the intervention group (Figure 3). It should
be noted that medical facilities in these 2 district hospi-
tals are quite comparable (Table 1). Three investigators
who are nephrologists [T.J., K.V., S.K.], will provide es-
sential knowledge about CKD care and treatments ac-
cording to NKF-K/DOQI guidelines to all staffs of both
groups [9].
In the control group, two general practitioners and
two chronic care nurses will provide CKD care to the
subjects according to treatment guidelines (Table 2). All
medical cares and educational programs will be provided
during their visit to the district hospital. Educational activ-
ities will be provided as group counseling. The educational
topics will be arranged sequentially i.e. basic knowledge
about CKD, optimal diet for pre-dialysis CKD patients,
effect of hypertension on CKD, relationship between
diabetes mellitus and CKD, drug use in CKD, and renal
replacement therapy.
Integrated CKD care program
In the intervention group, an integrated CKD care pro-
gram (ICP) will be implemented. The ICP is a collaborative
CKD care program. The key process is the cooperation be-
tween multidisciplinary team (MDT) and community CKD
care network (CCN). The MDT consists of two general
practitioners, two chronic care nurses, one pharmacist,
one nutritionist, and one physical therapist. Each CCN
Table 3 Intervention of the study
Figure 3 Design of the study.
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3–5 VHVs, and family members of the CKD patients re-
siding in the respective patient subdistrict.
In the pre-study period, a 4-day CKD care training-
course will be organized for members of CCN before
commencement of the intervention program. The training-
course contents include basic knowledge of CKD, NKF-K/
DOQI guidelines, and optimal diet for CKD patients. The
contents has been simplified to match with their basic
medical knowledges. Two dietitians [C.P., S.T.] will pro-
vide essential knowledge about collection and interpre-
tation methods of modified 24-h dietary recalls or Easy
Dietary Assessment tool (EDA) [13]. CCN members must
pass Pre/Post test evaluation with a minimum score of 75
percent preceeding commencement of the program.
After all staffs were completely trained, the MDT will
provide educational activities as live demonstration ofTable 2 Treatment guidelines for both treatment groups [8]
Clinical and laboratory parameters Treatment targets
Blood pressure Less than 130/80 mmHg
Body mass index 18.5-24.9 kg/m2
Hemoglobin More than 10 g/dl
HbA1C Less than 7%
LDL-cholesterol Less than 100 mg/dl
Serum bicarbonate More than 22 mEq/L
Urine protein-creatinine ratio Less than 500 mg/g
Sodium intake Less than 2,400 mg/day
Protein intake Less than 0.8 g/kg ideal
body weight /day
Smoking Smoking cessation
Physical exercise 30 minutes or more per
day 3 times a weekoptimal diets, medication, and exercise for CKD patients
during each hospital visit in addition to standard treat-
ments. Meanwhile, each subgroup of CCN will provide
home visits to their respective patients at 6–8 weeks
after each hospital visit. The activities during each home
visit will include the 4 main following issues: 24-h dieta-
ry recalls, blood pressure measurement, medication com-
pliance monitoring including avoidance of nephrotoxic
agents (e.g. NSAIDs), exercise monitoring, and 24-h diet-
ary recall. The CCN will ask 24-h dietary intake and will
use EDA tool to estimated dietary protein and sodium
intake and feedback the results to their patients dur-
ing each home visit. Details of clinical intervention during





Standard CKD care according to
NKF-K/DOQI guidelines
Yes Yes
Multidisciplinary team provide educational
activities during each hospital visit.
No Yes
Topics:
1. Optimal diets for CKD patients
2. CKD medications
3. Exercise for seniors




1. 24-hour dietary recall
2. Blood pressure measurement
3. Medication compliance monitoring
4. Exercise monitoring
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Patients in both groups will be scheduled to follow-up at
their respective district hospitals at every 3 months. Dur-
ing each hospital visit, blood pressure, body weight, and
waist circumference will be assessed. Laboratory meas-
urement will be done at enrollment, the first month and
every 3 months thereafter or when patients are with-
drawn from the study (Table 4). Blood pressure will be
recorded twice with a sphygmomanometer with a 15-
minute rest interval. The ACEi/ARBs dosages will be ad-
justed by the caring physicians. In case of any patient
develops intolerable side-effects of ACEi/ARBs, other
antihypertensive agents will be substituted.
Laboratory analysis
A protocol of laboratory investigation is summarized in
Table 4. Prior to each hospital visit, all subjects will be
instructed to have an 8-hour overnight fast. Plasma glu-
cose, lipid profile, HbA1C, albumin, electrolytes, and urine
analysis will be measured in the next morning. After cen-
trifugation, plasma and urine samples will be centrifuged
and transported at 4°C and analyzed within 24 hours at
the laboratory Department of the District 2 Hospital. All
blood chemistries will be measured with ABX Pentra 400
analyzer (HORIBA ABX S.A.S., France). Urine protein and
creatinine will be measured with the pyrogallol red colori-
metric method with the same analyzer. All biochemistry
analyses will be validated according to the standard proto-
col of Department of Medical Sciences, Ministry of Public
Health, Thailand. Serum creatinine will be measured by
the enzymatic method. Serum creatinine measurement will
be standardized with standard reference material (SRM
967) by commutability study at every 6 months [14].
Two out of twelve subgroups of both groups will be ran-
domly selected and assigned to collect 24-hour urine. An





Blood pressure, body weight, waist circumference √ √ √
Serum creatinine √ √ √
eGFR √ √ √
Serum potassium - - √
Phosphate, Calcium, Albumin - √ -
Hemoglobin - √ -
HbA1C - √ -
LDL-cholesterol - √ -
Urine dipstick protein - √ -
Urine protein -creatinine ratio - √ -
24-hour Urine for Na, Urea-N, Creatinine, Protein - √ -urine chemistry analysis protein, creatinine, urea, and so-
dium at Laboratory Department of Division of Nephrology,
Chulalongkorn University, Bangkok, Thailand.
Outcomes
The primary outcome of this study is the difference of
rate of eGFR decline. The secondary outcomes are la-
boratory parameters (Table 4) and incidence of clinical
endpoints including all-cause mortality, cardiovascular
events (acute myocardial infarction and stroke), ESRD
(eGFR is less than 15 ml/min/1.73 m2), and 50% increase
in serum creatinine from baseline. In this study, acute
myocardial infarction is defined as a new ischemic pat-
tern change of ECG and significant rising of cardiac
enzymes. Acute stroke is defined as there is a clinical
significant neurological deficit with an objective evi-
dence by appropriate imaging study (e.g. computerized
tomography scan). Patients will be followed at the first
month and every three months after enrollment. Sub-
group analysis will be done for selected parameters includ-
ing age, sex, and diabetes mellitus. Quality of life will be
assessed using a validated questionnaire, Thai SF-36 health
survey [15].
Statistical analysis
Analysis of the primary outcome will be based on an
intention-to-treat basis. Descriptive statistics will be ex-
pressed as the mean and standard deviation. Discrete
variables will be presented as frequency and percentage.
An independent t-test will be applied to compare mean
values and mean differences between intervention and
control groups. Differences between categorical variables
will be analysed with Chi-square or Fisher’s exact tests.
The comparison of the rate of eGFR decline will be ana-
lyzed using linear mixed models (Generalized Estima-
ting Equation) [16]. The difference of incidence of clinicalg the study period
2 Visit 3 Visit 4 Visit 5 Visit 6 Visit 7 Visit 8 Visit 9 Visit 10
3 6 9 12 15 18 21 24
√ √ √ √ √ √ √ √
√ √ √ √ √ √ √ √
√ √ √ √ √ √ √ √
- √ - √ - √ - √
- √ - √ - √ - √
- √ - √ - √ - √
- √ - √ - √ - √
- √ - √ - √ - √
- √ - √ - √ - √
√ √ √ √ √ √ √ √
- √ - √ - √ - √
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All statistical tests will be two-tailed tests. A P-value of
less than 0.05 will be considered statistically significant.
The data will be analysed using SPSS 16.0 (SPSS Inc.,
Chicago, IL, USA).
Discussion
Currently, Thailand has a population of approximately
66 million, in which 55 percent of the population live in
rural areas [17,18]. In these areas, the number of special-
ized personnel is limited and work burden is overwhelm-
ing, good clinical care and equal accessibility to the care
may be too difficult to achieve. Utilizing renal physi-
cians, or even internists, to take care of CKD patients in
rural area is rather far from reality. To combat these prob-
lems, we try to search for an appropriate CKD care model
which could provide optimal treatment to the rural po-
pulation. To the best of our knowledge, this study is the
first large-scale, community-based cluster randomized
controlled trial to study the effect of employing an inte-
grated CKD care which is comprised of multidisciplinary
CKD care program in conjunction with well-trained para-
medical personnel on delaying CKD progression.
In addition to conventional CKD treatment, the two
key processes will be added into the intervention group.
Firstly, the multidisciplinary team of district hospital
staffs will provide demonstration about essential know-
ledge CKD care during each hospital visit. We hypothe-
sized that this interactive activity will provide better
understanding of essential medical knowledge and in-
crease awareness of burden of CKD and ESRD. The sec-
ond process is quarterly home visit by the CCN. We
trained the CCN and endorsed them to work as the es-
corts (as the abbreviation name of the study) to protect
CKD patients. The important roles of CCN is monitor-
ing compliance to the treatments and instantly feedback
to the patients. These important informations will be
used to modify lifestyle of CKD patients and may im-
prove compliance to the treatments.
Interestingly, the integration of both processes will in-
crease frequency personnel to patients contact compen-
sating for physician to patient contact time which may
improve compliance of drug usage and dietary control;
furthermore, the continuity of monitoring might be a
key mechanism for sustainable self-behavioral modifica-
tion. We expect the results of this study will set forth a
new standard of community-based CKD care for Thailand.
Limitation of the study
We conducted cluster randomized control trial instead
of double-blinded randomized control trial in any dis-
trict, for patients who reside in the same district may
imitate the way of practice of each group of the study.
Due to ethical consideration, the control group have toinevitably provide essential knowledge according to stan-
dard guidelines which may improve their rate of eGFR
decline. Finally, the interventions of this study are multi-
factorial design, so we are unable to determine the single
risk factors and need further investigation to identify de-
terminant factor for behavioral modification.
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